INNOVOTEX Inc., a pharmaceutical company advancing a new class of tumor-selective oncology therapeutics known as Macrocycle Drug Conjugates (MDCs), today announced the appointment of Dr. Krystle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results